Safety Study of Combination Chemotherapy in Patients With Metastatic Solid Tumors or Adenocarcinoma of the Pancreas
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to determine the maximum tolerated dose and the dose-limiting
toxicity of biweekly oxaliplatin in combination with fixed doses of irinotecan,
5-fluorouracil/leucovorin and gemcitabine in patients with metastatic solid tumors or
adenocarcinoma of the pancreas.